How to approach neutropenia in childhood

Pediatrics in Review

Volumn 34, Issue 4, 2013, Pages 173-184

  Walkovich, Kelly ^a   Boxer, Laurence A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABNORMAL LABORATORY RESULT; ANTIBIOTIC THERAPY; ARTICLE; AUTOIMMUNE NEUTROPENIA OF INFANCY; BACTERIAL INFECTION; BLOOD CELL COUNT; BONE MARROW CELL; CASE REPORT; CELL MATURATION; CELL PROLIFERATION; CHILD; DISEASE SEVERITY; FEVER; GINGIVITIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFANT DISEASE; INFECTION RISK; MALE; MORTALITY; MOUTH ULCER; MYELOPOIESIS; NEUTROPENIA; OTITIS MEDIA; PATIENT CARE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; RECURRENT DISEASE; SEVERE CONGENITAL NEUTROPENIA;

CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFANT; INFECTION; MALE; NEUTROPENIA;

EID: 84877256413     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.34-4-173     Document Type: Article

References (13)

1. Dale DC, Cottle TE, Fier CJ, et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol. 2003;72(2): 82-93 (Pubitemid 36164341)
2. Levine DH, Madyastha PR. Isoimmune neonatal neutropenia. Am J Perinatol. 1986;3(3):231-233 (Pubitemid 16059837)
3. Dale DC, Bonilla MA, Davis MW, et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood. 1993;81(10):2496-2502 (Pubitemid 23147550)
4. Andrès E, Zimmer J, Mecili M, Weitten T, Alt M, Maloisel F. Clinical presentation and management of drug-induced agranulocytosis. Expert Rev Hematol. 2011;4(2):143-151
5. Boxer LA, Newburger PE. A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer. 2007;49(5): 609-614 (Pubitemid 350194422)
6. Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood. 2000;96(7):2317-2322
7. Donadieu J, Fenneteau O, Beaupain B, Mahlaoui N, Chantelot CB. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis. 2011;6:26
8. Fioredda F, Calvillo M, Bonanomi S, et al. Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica). Am J Hematol. 2011;57:10-17
9. Grann VR, Ziv E, Joseph CK, et al. Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol. 2008;143(2): 288-293
10. Klein C. Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes. Annu Rev Immunol. 2011;29:399-413
11. Levine DH, Madyastha PR. Isoimmune neonatal neutropenia. Am J Perinatol. 1986;3(3):231-233 (Pubitemid 16059837)
12. Newburger PE, Boxer LA. Leukopenia. In: Kliegman RM, Stanton BF, St Gene IW III, Schor NF, Behrman RE, eds. Nelson Textbook of Pediatrics. 19th ed. Philadelphia, PA: Elsevier Saunders; 2011:746-751
13. Newburger PE, Pindyck TN, Zhu Z, et al. Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes. Pediatr Blood Cancer. 2010;55(2):314-317